Belgium· BE-AMP-SAM319681-00
Epirubicine Sandoz 2 mg/ml
A epirubicin product containing epirubicin hydrochloride, registered in Belgium by Sandoz. The same ATC class is registered in 17 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Epirubicin is registered in 17 of 19 countries.
Countries holding a registration under ATC L01DB03 (epirubicin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Epirubicin · ATC L01DB03
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of epirubicin costs, country by country.
Normalised to the WHO defined daily dose (7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Epirubicin · price per daily dose (7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$15.02
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Epirubicin Hydrochloride
- Manufacturer
- Sandoz
- Country
- Belgium (BE)
- ATC code
- L01DB03
- ATC class
- Epirubicin
- Defined daily dose
- 7 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
- be_apb3040375
- be_apb0790600
- be_apb3040383
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
560 interactions on record for epirubicin.
Graded by severity as the source publishes them — 100 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Epirubicin · interactions on record
560 records
- 100 severe
- 450 moderate
- 10 minor
Most severe, free to view
- CimetidineA02BA01severe
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Epirubicin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEPIRUBICIN ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- United StatesEllencePharmacia & Upjohn Company LLC
- FinlandEpirubicin Fresenius KabiFresenius Kabi Oncology Plc.
- SpainEPIRUBICINA ACCORD 2 mg/ml SOLUCION INYECTABLE O PARA PERFUSION EFGAccord Healthcare S.L.U.
- IrelandEpirubicin 2 mg/ml Solution for InjectionSeacross Pharma (Europe) Limited
- SwedenEpirubicin Accord 2 mg/ml Injektions-/infusionsvätska, lösningAccord Healthcare B.V.
- NorwayEpirubicin AccordAccord Healthcare B.V.
- PolandEpirubicin AccordAccord Healthcare Polska Sp. z o.o.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Epirubicin Accord, Epirubicin Ebewe
- Bulgaria · Епирубицин Ебеве, Еписиндан
- Cyprus · Epirubicin Aqvida, Farmorubicin
- Czechia · Epirubicin Accord, Epirubicin Teva
- Germany · Bendaepi, Epi
- Denmark · Epirubicin "medac", Epirubicin Accord
- Estonia · Epirubicin Accord
- Spain · Epirubicina Accord, Epirubicina Aurovitas
- Finland · Epirubicin Accord, Epirubicin Ebewe
- France · Epirubicine Accord, Epirubicine Hikma
- United Kingdom (Northern Ireland) · Epirubicin, Epirubicin Hydrochloride Accord Healthcare
- Greece · Epirubicin Hydrochloride Pharmachemie, Epirubicin Viatris
- Hungary · Epirubicin Accord, Epirubicin Sandoz
- Ireland · Epirubicin Hydrochloride Accord Healthcare Ireland, Epirubicin Seasec Pharmaceutical
- Iceland · Epirubicin Actavis
- Italy · Epirubicina Ahcl, Epirubicina Hikma
- Lithuania · Epirubicin Accord
- Luxembourg · Epirubicin Eugia, Epirubicine Teva
- Latvia · Epirubicin Accord
- Malta · Epirubicin Hydrochloride Accord Healthcare
- Netherlands · Epirubicine Hcl Pharmachemie, Epirubicine Hikma
- Norway · Epirubicin Accord, Epirubicin Ebewe
- Poland · Epirubicin Accord, Epirubicin Ebewe
- Portugal · Epirrubicina Accord, Epirrubicina Adoh
- Romania · Epirubicină Teva
- Sweden · Epirubicin Accord, Epirubicin Ebewe
- Slovenia · Epirubicin Ebewe, Epirubicin Teva
- Slovakia · Epimedac, Epirubicín Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6791e86-72f4-48dc-a50b-8a024471132e GET /v1/drugs/e6791e86-72f4-48dc-a50b-8a024471132e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection/infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Epirubicine Sandoz 2 mg/ml",
"name_fr": "Epirubicine Sandoz 2 mg/ml",
"name_nl": "Epirubicine Sandoz 2 mg/ml",
"amp_code": "SAM319681-00",
"strengths": [
"2.0000"
],
"pack_count": 3,
"substances": [
"Epirubicin Hydrochloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Epirubicin",
"authorisation_numbers": [
"BE319681"
]
}See everything about epirubicin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.